Answers are grounded in this paper and cite their sources.
Skin complications related to CSII or CGM devices are commonly reported in pediatric patients with type 1 diabetes and may lead to interruption or discontinuation of device use. Future studies are needed to elucidate the causes of these reactions and determine the best methods for prevention.
No takes yet. Share an insight, caveat, or question.
Rigo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: